Both in Pharmaceuticals
Viridian Therapeutics vs IDEAYA Biosciences
Over the past year VRDN returned +8.6% and IDYA returned −0.1%; their daily moves had a correlation of 0.21.
VRDN +8.6% IDYA −0.1%Growth of $1, one year, split-adjusted
| Metric | VRDN | IDYA |
|---|---|---|
| Price | $25.15 | $31.33 |
| Market cap | $2.85B | $3.02B |
| Today | −0.59% | −0.98% |
| 1 month | +32.4% | −17.7% |
| 6 months | +34.1% | +8.8% |
| Year to date | −19.2% | −9.4% |
| 1 year | +6.4% | −1.7% |
| Revenue growth (YoY) | +278.7% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −39726.8% | −1269.6% |
| P/E (TTM) | — | — |
| Price / sales | 40.1× | 12.9× |
| Net cash | $625.7M | $829.0M |
| Dividend yield | — | — |
| Volatility (60d) | 47.3% | 37.0% |
| Short % of float | 18.5% | 10.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).